Detalles de la búsqueda
1.
Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study.
Scand J Rheumatol;
50(3): 178-182, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33432861
2.
Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.
Scand J Rheumatol;
48(5): 362-366, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244356
3.
Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.
Scand J Rheumatol;
47(6): 465-474, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30070923
4.
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
Lancet;
374(9688): 459-66, 2009 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19665644
5.
Creating a culture of health: evolving healthcare systems and patient engagement.
QJM;
110(3): 125-129, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27803364
6.
Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
Scand J Rheumatol;
35(3): 182-8, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16766364
7.
Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.
Scand J Rheumatol;
34(5): 353-8, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16234182
8.
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
Rheumatology (Oxford);
41(5): 484-9, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12011369
9.
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.
Ann Rheum Dis;
62(6): 526-9, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12759288
Resultados
1 -
9
de 9
1
Próxima >
>>